Professor Lencioni ILCA 2011.pdf - Biocompatibles
Professor Lencioni ILCA 2011.pdf - Biocompatibles
Professor Lencioni ILCA 2011.pdf - Biocompatibles
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
DEBDOX vs cTACE: Response rates are higherin patients with more advanced diseaseDEBDOX shows significant advantagefor objective response (p=0.038)and disease control (p=0.026)Lammer J et al. Cardiovasc Intervent Radiol 2010;33:41-52